Identification of Discrete Prognostic Groups in Ewing Sarcoma

作者: Erin E. Karski , Elizabeth McIlvaine , Mark R. Segal , Mark Krailo , Holcombe E. Grier

DOI: 10.1002/PBC.25709

关键词:

摘要: Background Although multiple prognostic variables have been proposed for Ewing sarcoma (EWS), little work has done to further categorize these into groups risk classification. Procedure We derived initial from 2,124 patients with EWS in the SEER database. We constructed a multivariable recursive partitioning model of overall survival using following covariates: age; stage; race/ethnicity; sex; axial primary; pelvic and bone or soft tissue primary. Based on this model, we identified estimated 5-year each group Kaplan–Meier methods. then applied 1,680 enrolled COG clinical trials. Results A five significantly different survival: (i) localized, age <18 years, non-pelvic (ii) <18, primary ≥18, white, non-Hispanic; (iii) all races/ethnicities other than (iv) metastatic, <18; (v) ≥18. These were dataset showed event-free based upon classification system (P < 0.0001). A sub-analysis treated ifosfamide etoposide as component therapy evaluated findings receiving contemporary therapy. Conclusions Recursive analysis yields discrete that provide valuable information clinicians determining an individual patient's death. may enable future trials adjust treatment according individualized risk. Pediatr Blood Cancer © 2015 Wiley Periodicals, Inc.

参考文章(28)
R. Sauer, H. Jürgens, J.M.V. Burgers, J. Dunst, R. Hawlicek, J. Michaelis, Prognostic factors in the treatment of Ewing's sarcoma Radiotherapy and Oncology. ,vol. 10, pp. 101- 110 ,(1987) , 10.1016/S0167-8140(87)80052-X
Carlos Rodríguez-Galindo, Tiebin Liu, Matthew J. Krasin, Jianrong Wu, Catherine A. Billups, Najat C. Daw, Sheri L. Spunt, Bhaskar N. Rao, Victor M. Santana, Fariba Navid, Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies. Cancer. ,vol. 110, pp. 375- 384 ,(2007) , 10.1002/CNCR.22821
Paul A. Meyers, Mark D. Krailo, Marc Ladanyi, Ka-Wah Chan, Scott L. Sailer, Paul S. Dickman, David L. Baker, Jeffrey H. Davis, Robert B. Gerbing, Alfred Grovas, Cynthia E. Herzog, Karen L. Lindsley, Wen Liu-Mares, James B. Nachman, Lance Sieger, Jean Wadman, Richard G. Gorlick, High-Dose Melphalan, Etoposide, Total-Body Irradiation, and Autologous Stem-Cell Reconstitution as Consolidation Therapy for High-Risk Ewing’s Sarcoma Does Not Improve Prognosis Journal of Clinical Oncology. ,vol. 19, pp. 2812- 2820 ,(2001) , 10.1200/JCO.2001.19.11.2812
Sebastian Pieper, Andreas Ranft, Gabriele Braun-Munzinger, Heribert Jürgens, Michael Paulussen, Uta Dirksen, Ewing's tumors over the age of 40: a retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99. Onkologie. ,vol. 31, pp. 657- 663 ,(2008) , 10.1159/000165361
Abha A. Gupta, Alberto Pappo, Natasha Saunders, Sevan Hopyan, Peter Ferguson, Jay Wunder, Brian O'Sullivan, Charles Catton, Mark Greenberg, Martin Blackstein, Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer. ,vol. 116, pp. 3189- 3194 ,(2010) , 10.1002/CNCR.25144
Gaetano Bacci, Alba Balladelli, Cristiana Forni, Stefano Ferrari, Alessandra Longhi, Patrizia Bacchini, Marco Alberghini, Nicola Fabbri, MariaSerena Benassi, Antonio Briccoli, Piero Picci, Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years. Cancer. ,vol. 109, pp. 780- 786 ,(2007) , 10.1002/CNCR.22456
Jacob G. Scott, Luc Bauchet, Tyler J. Fraum, Lakshmi Nayak, Anna R. Cooper, Samuel T. Chao, John H. Suh, Michael A. Vogelbaum, David M. Peereboom, Sonia Zouaoui, Hélène Mathieu-Daudé, Pascale Fabbro-Peray, Valérie Rigau, Luc Taillandier, Lauren E. Abrey, Lisa M. DeAngelis, Joanna H. Shih, Fabio M. Iwamoto, Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older Cancer. ,vol. 118, pp. 5595- 5600 ,(2012) , 10.1002/CNCR.27570
Muhammad U. Jawad, Michael C. Cheung, Elijah S. Min, Michaela M. Schneiderbauer, Leonidas G. Koniaris, Sean P. Scully, Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: An analysis of 1631 cases from the SEER database, 1973-2005 Cancer. ,vol. 115, pp. 3526- 3536 ,(2009) , 10.1002/CNCR.24388
Jennifer Worch, Katherine K. Matthay, John Neuhaus, Robert Goldsby, Steven G. DuBois, Ethnic and racial differences in patients with Ewing sarcoma Cancer. ,vol. 116, pp. 983- 988 ,(2010) , 10.1002/CNCR.24865
Joe Lee, Bang H. Hoang, Argyrios Ziogas, Jason A. Zell, Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer. ,vol. 116, pp. 1964- 1973 ,(2010) , 10.1002/CNCR.24937